Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Mary E. Charlson, Peter Pompei, Kathy L. Aleš et al. · Journal of Chronic Diseases · 1987 · 49.9K citations

Public Health, Biostatistics, Clinical Classification Systems +15

Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

Claire Bombardier, Loren Laine, Alise Reicin et al. · New England Journal of Medicine · 2000 · 4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis

Fred E. Silverstein, Gerald A. Faich, Jay L. Goldstein et al. · JAMA · 2000 · 3.2K citations

Medicine, Pharmacology, Pharmacotherapy +16

Performance of Comorbidity Scores to Control for Confounding in Epidemiologic Studies using Claims Data

American Journal of Epidemiology · 2001 · 718 citations · Full text

Public Health, Pharmacotherapy, Clinical Epidemiology +16

Effects of Specific Inhibition of Cyclooxygenase-2 on Sodium Balance, Hemodynamics, and Vasoactive Eicosanoids

Francesca Catella-Lawson, Brendan McAdam, Briggs Morrison et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 595 citations

Medicine, Pharmacology, Pharmacotherapy +16